Stryker Corporation’s Neurotechnology and MedSurg businesses were the major drivers of its solid organic growth in 2021. The company was affected by a slowdown in the sales of the spine, knee, and hip because of the resurgence of the pandemic. Though its implant business diminished, Stryker saw the robust result for its capital products and Mako product technology over its MedSurg portfolio. A slowdown in deferrable patterns has impacted the U.S. and has weakened throughout the year. Stryker had ....
27 Apr 2022
Stryker Corporation: Detailed Credit Analysis & Financial Strength Evaluation Report, Key Risks & ESG Assessment (04/2022)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Stryker Corporation: Detailed Credit Analysis & Financial Strength Evaluation Report, Key Risks & ESG Assessment (04/2022)
- Published:
27 Apr 2022 -
Author:
Ishan Majumdar -
Pages:
17
Stryker Corporation’s Neurotechnology and MedSurg businesses were the major drivers of its solid organic growth in 2021. The company was affected by a slowdown in the sales of the spine, knee, and hip because of the resurgence of the pandemic. Though its implant business diminished, Stryker saw the robust result for its capital products and Mako product technology over its MedSurg portfolio. A slowdown in deferrable patterns has impacted the U.S. and has weakened throughout the year. Stryker had ....